Dimorphic effects of leptin on the circadian and hypocretinergic systems of mice

Journal of Neuroendocrinology

Volumn 23, Issue 1, 2011, Pages 28-38

  Mendoza, J ^a   Lopez Lopez, C ^b   Revel, F G ^b   Jeanneau, K ^b   Delerue, F ^b   Prinssen, E ^b   Challet, E ^a   Moreau, J ^b   Grundschober, C ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Preclinical Research   (Switzerland)

Author keywords

Circadian rhythms; Dimorphic; Hypocretin; Leptin; Sleep wake cycle

Indexed keywords

LEPTIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; PER1 PROTEIN; PER2 PROTEIN; PROTEIN C FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CIRCADIAN RHYTHM; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; DARKNESS; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FOOD INTAKE; HYPOTHALAMUS NUCLEUS; IN VIVO CULTURE; LIGHT DARK CYCLE; LOCOMOTION; MALE; MOUSE; NERVE CELL; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS;

ANIMALS; BLOTTING, WESTERN; CIRCADIAN RHYTHM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; LOCOMOTION; MALE; MICE; MICE, INBRED C57BL; NEURONS; NEUROPEPTIDES; SUPRACHIASMATIC NUCLEUS;

EID: 78650206411     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2010.02072.x     Document Type: Article

References (57)

1. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671.
2. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996; 17: 305-311.
3. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, Elmquist JK. Chemical characterization of leptin activated neurons in the rat brain. J Comp Neurol 2000; 423: 261-281.
4. Elmquist JK, Ahima RS, Maratos Flier E, Flier JS, Saper CB. Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 1997; 138: 839-842.
5. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB. Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad Sci USA 1998; 95: 741-746.
6. Guan XM, Hess JF, Yu H, Hey PJ, van der Ploeg LH. Differential expression of mRNA for leptin receptor isoforms in the rat brain. Mol Cell Endocrinol 1997; 133: 1-7.
7. Hakansson M, de Lecea L, Sutcliffe JG, Yanagisawa M, Meister B. Leptin receptor and STAT3 immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. J Neuroendocrinol 1999; 11: 653-663.
8. Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, Tominaga M, Yagami K, Sugiyama F, Goto K, Yanagisawa M, Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003; 38: 701-713.
9. Ahrén B. Diurnal variation in circulating leptin is dependent on gender, food intake and circulating insulin in mice. Acta Physiol Scand 2000; 169: 325-331.
10. Kalsbeek A, Fliers E, Romijn JA, LaFleur SE, Wortel J, Bakker O, Endert E, Buijs RM. The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology 2001; 142: 2677-2685.
11. Randeva HS, Karteris E, Lewandowski KC, Sailesh S, O'Hara P, Hillhouse EW. Circadian rhythmicity of salivary leptin in healthy subjects. Mol Genet Metab 2003; 78: 229-235.
12. Karakas A, Gündüz B. Suprachiasmatic nuclei may regulate the rhythm of leptin hormone release in Syrian hamsters (Mesocricetus auratus). Chronobiol Int 2006; 23: 225-236.
13. Prosser RA, Bergeron HE. Leptin phase advances the rat suprachiasmatic circadian clock in vitro. Neurosci Lett 2003; 336: 139-142.
14. Inyushkin AN, Bhumbra GS, Dyball RE. Leptin modulates spike coding in the rat suprachiasmatic nucleus. J Neuroendocrinol 2009; 21: 705-714.
15. Martínez Merlos MT, Angeles Castellanos M, Díaz Muñoz M, Aguilar Roblero R, Mendoza J, Escobar C. Dissociation between adipose tissue signals, behavior and the food entrained oscillator. J Endocrinol 2004; 181: 53-63.
16. Deurveilher S, Semba K. Indirect projections from the suprachiasmatic nucleus to major arousal promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience 2005; 130: 165-183.
17. Zhang S, Zeitzer JM, Yoshida Y, Wisor JP, Nishino S, Edgar DM, Mignot E. Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin 1 release. Sleep 2004; 27: 619-627.
18. Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000; 62: 161-168.
19. Adamantidis A, de Lecea L. The hypocretins as sensors for metabolism and arousal. J Physiol 2009; 587: 33-40.
20. Lindemann L, Meyer CA, Jeanneau K, Bradaia A, Ozmen L, Bluethmann H, Bettler B, Wettstein JG, Borroni E, Moreau JL, Hoener MC. Trace amine associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 2008; 324: 948-956.
21. Lopez Lopez C, LeRoith D, Torres Aleman I. Insulin like growth factor I is required for vessel remodeling in the adult brain. Proc Natl Acad Sci USA 2004; 101: 9833-9838.
22. Reed MG, Howard CV. Surface weighted star volume: concept and estimation. J Microsc 1998; 190: 350-356.
23. Wiebel ER. Stereological Methods. Practical Methods for Biological Morphometry. London: Academic Press, 1979.
24. Harvey J, Ashford ML. Leptin in the CNS: much more than a satiety signal. Neuropharmacology 2003; 44: 845-854.
25. Valerio A, Ghisi V, Dossena M, Tonello C, Giordano A, Frontini A, Ferrario M, Pizzi M, Spano P, Carruba MO, Nisoli E. Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase 3beta. J Biol Chem 2006; 281: 12950-12958.
26. Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci USA 1996; 93: 1726-1730.
27. Yannielli PC, Molyneux PC, Harrington ME, Golombek DA. Ghrelin effects on the circadian system of mice. J Neurosci 2007; 27: 2890-2895.
28. Schwartz WJ, Zimmerman P. Circadian timekeeping in BALB/c and C57BL/6 inbred mouse strains. J Neurosci 1990; 10: 3685-3694.
29. Albrecht U, Sun ZS, Eichele G, Lee CC. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 1997; 91: 1055-1064.
30. Yi CX, Challet E, Pévet P, Kalsbeek A, Escobar C, Buijs RM. A circulating ghrelin mimetic attenuates light induced phase delay of mice and light induced Fos expression in the suprachiasmatic nucleus of rats. Eur J Neurosci 2008; 27: 1965-1972.
31. Sans Fuentes MA, Díez Noguera A, Cambras T. Light responses of the circadian system in leptin deficient mice. Physiol Behav 2010; 99: 487-494.
32. Mendoza J. Circadian clocks: setting time by food. J Neuroendocrinol 2007; 19: 127-137.
33. Bodosi B, Gardi J, Hajdu I, Szentirmai E, Obal F Jr, Krueger JM. Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1071-R1079.
34. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006; 393: 7-20.
35. Coogan AN, Piggins HD. MAP kinases in the mammalian circadian system key regulators of clock function. J Neurochem 2004; 90: 769-775.
36. Ono T, Nishino H, Fukuda M, Sasaki K, Muramoto K, Oomura Y. Glucoresponsive neurons in rat ventromedial hypothalamic tissue slices in vitro. Brain Res 1982; 232: 494-499.
37. Dhillon H, Zigman JM, Ye C, Lee CE, McGovern RA, Tang V, Kenny CD, Christiansen LM, White RD, Edelstein EA, Coppari R, Balthasar N, Cowley MA, Chua S Jr, Elmquist JK, Lowell BB. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body weight homeostasis. Neuron 2006; 49: 191-203.
38. Challet E, Bernard DJ, Turek FW. Lesions of glucose responsive neurons impair synchronizing effects of calorie restriction in mice. Brain Res 1998; 801: 244-250.
39. Moga MM, Moore RY. Putative excitatory amino acid projections to the suprachiasmatic nucleus in the rat. Brain Res 1996; 743: 171-177.
40. Klisch C, Inyushkin A, Mordel J, Karnas D, Pévet P, Meissl H. Orexin A modulates neuronal activity of the rodent suprachiasmatic nucleus in vitro. Eur J Neurosci 2009; 30: 65-75.
41. Coppari R, Ichinose M, Lee C, Pullen AE, Kenny CD, McGovern RA, Tang V, Ludwig T, Chua SC, Lowell BB, Elmquist JK. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab 2005; 1: 63-72.
42. Sunter D, Morgan I, Edwards CM, Dakin CL, Murphy KG, Gardiner J, Taheri S, Rayes E, Bloom SR. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res 2001; 907: 27-34.
43. Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, Leonard CS, Richardson JA, Hammer RE, Yanagisawa M. Distinct narcolepsy syndromes in Orexin receptor 2 and Orexin null mice: molecular genetic dissection of Non REM and REM sleep regulatory processes. Neuron 2003; 38: 715-730.
44. Sinton CM, Fitch TE, Gershenfeld HK. The effects of leptin on REM sleep and slow wave delta in rats are reversed by food deprivation. J Sleep Res 1999; 8: 197-203.
45. Laposky AD, Shelton J, Bass J, Dugovic C, Perrino N, Turek FW. Altered sleep regulation in leptin deficient mice. Am J Physiol Regul Integr Comp Physiol 2006; 290: R894-R903.
46. Laposky AD, Bradley MA, Williams DL, Bass J, Turek FW. Sleep wake regulation is altered in leptin resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 2008; 295: R2059-R2066.
47. Haynes AC, Chapman H, Taylor C, Moore GB, Cawthorne MA, Tadayyon M, Clapham JC, Arch JR. Anorectic, thermogenic and anti obesity activity of a selective orexin 1 receptor antagonist in ob/ob mice. Regul Pept 2002; 104: 153-159.
48. Krajnak K, Kashon ML, Rosewell KL, Wise PM. Sex differences in the daily rhythm of vasoactive intestinal polypeptide but not arginine vasopressin messenger ribonucleic acid in the suprachiasmatic nuclei. Endocrinology 1998; 139: 4189-4196.
49. Dardente H, Poirel VJ, Klosen P, Pévet P, Masson Pévet M. Per and neuropeptide expression in the rat suprachiasmatic nuclei: compartmentalization and differential cellular induction by light. Brain Res 2002; 958: 261-271.
50. Karatsoreos IN, Silver R. Minireview: The neuroendocrinology of the suprachiasmatic nucleus as a conductor of body time in mammals. Endocrinology 2007; 148: 5640-5647.
51. Janeckova R. The role of leptin in human physiology and pathophysiology. Physiol Res 2001; 50: 443-459.
52. Akhter N, Johnson BW, Crane C, Iruthayanathan M, Zhou YH, Kudo A, Childs GV. Anterior pituitary leptin expression changes in different reproductive states: stimulation, in vitro, by gonadotropin releasing hormone (GnRH). J Histochem Cytochem 2007; 55: 151-166.
53. Bennett PA, Lindell K, Karlsson C, Robinson IC, Carlsson LM, Carlsson B. Differential expression and regulation of leptin receptor isoforms in the rat brain: effects of fasting and oestrogen. Neuroendocrinology 1998; 67: 29-36.
54. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 2001; 25: 1680-1688.
55. Lu XY, Kim CS, Frazer A, Zhang W. Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 2006; 103: 1593-1598.
56. Kuru M, Ueta Y, Serino R, Nakazato M, Yamamoto Y, Shibuya I, Yamashita H. Centrally administered orexin/hypocretinactivates HPA axis in rats. Neuroreport 2000; 11: 1977-1980.
57. Sakamoto F, Yamada S, Ueta Y. Centrally administered orexin A activates corticotropin releasing factor containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stressactivated central CRF neurons. Regul Pept 2004; 118: 183-191.